Market Crash: Top 6 Biotech Stocks to Buy Amidst the Carnage (The Market Cap)

Undervalued Biotech Stocks After the Market Selloff

Ensure you continue to get this valuable content by whitelisting us (find out how here).

Monday, August 24, 2015 Edit Subscriber Profile  |  Unsubscribe  |  Privacy Policy

Special Alert: "Get rid of everything on this red flag list now" ...warns former hedge fund manager, Teeka Tiwari. "Then check out this one 'safe haven' company that could pay you as high a yield as 12-13% and make investors a fortune..." (Details here.)

FEATURE

Market Crash: Top 6 Biotech Stocks to Buy Amidst the Carnage If you missed out on Bret Jensen's unrivaled gains in the biotech sector, like 464% from Eagle Pharmaceuticals in six months, a new buying opportunity just presented itself. After the market collapse last week, Bret is issuing a strong buy for six biotech stocks that are now undervalued. Get his top picks for the rebound. Click to read more

EDITOR'S PICKS Undervalued Stocks: 3 Refining Stocks About to Report Record Profits Ex-Banker Reveals: "This Pays 60 Times More Interest Than Your Bank" [ad] OUR TOP INVESTING IDEAS   This Dividend Stock Is Too Good to Be True With its recent April 2015 IPO, this new high-yield dividend stock is making an exciting entrance into the market. A 10% yield and an enthusiastic management team with visions of high growth caught Tim Plaehn's attention, but is the company just blowing hot air? Click to read more Sell This High Flying Stock Before It's Too Late This popular stock, a favorite of retail investors, has been on a tear jumping 72% year-to-date. But the valuation is being stretched beyond any realistic foundations. Now is the time to sell this dangerous stock that may be lurking in your portfolio. Click to read more

© Copyright 1998-2015, Investors Alley Corp. All rights reserved. See Privacy Policy and Terms of Use | Contact Us

 

If you enjoyed reading this email, click here to forward it to a friend or colleague.

You are receiving this message because you registered ignoble.experiment@arconati.us through INO.com Invite Sell - Apr 2014.
Click here to send us comments or questions regarding this mailing. Unsubscribe/update profile using link below.

This message from Investors Alley Corp. is being sent in full accordance with the CAN-SPAM Act.
We respect your privacy and, therefore, this email was sent directly from Investors Alley.  Please review our Privacy Statement and Terms of Use. 
If you no longer wish to receive emails from Investors Alley, please opt-out using the link below.

The opinions in this email and corresponding web sites are neither an offer nor a recommendation to buy or sell any security. Investors Alley Corp. and its affiliates may hold a position in any of the companies mentioned.  Investors Alley Corp. is not a registered investment firm nor a broker/dealer.  We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.

All information contained herein is copyright 2015, Investors Alley Corp.
Investors Alley Corporation | 41 Madison Avenue | 31st Floor | New York, NY  10010

 

Update Your Profile Information | Modify Subscription Settings or Unsubscribe From Emails